ES2075249T3 - Dispositivo adhesivo para la administracion transdermica de un agente activo. - Google Patents

Dispositivo adhesivo para la administracion transdermica de un agente activo.

Info

Publication number
ES2075249T3
ES2075249T3 ES91105933T ES91105933T ES2075249T3 ES 2075249 T3 ES2075249 T3 ES 2075249T3 ES 91105933 T ES91105933 T ES 91105933T ES 91105933 T ES91105933 T ES 91105933T ES 2075249 T3 ES2075249 T3 ES 2075249T3
Authority
ES
Spain
Prior art keywords
cir
plaster layer
ingredient
active agent
percutaneous absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91105933T
Other languages
English (en)
Inventor
Akihito Yamanaka
Saburo Otsuka
Yoshifumi Hosaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nitto Denko Corp
Takeda Pharmaceutical Co Ltd
Original Assignee
Nitto Denko Corp
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp, Takeda Chemical Industries Ltd filed Critical Nitto Denko Corp
Application granted granted Critical
Publication of ES2075249T3 publication Critical patent/ES2075249T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN ADHESIVO MEDICO QUE COMPRENDE UNA CAPA DE EMPLASTO QUE CONTIENE LOS SIGUIENTES INGREDIENTES, CARACTERIZADA POR QUE EL INGREDIENTE (2) SE INCORPORA EN CANTIDAD MAYOR QUE EL INGREDIENTE (5) Y EN CANTIDAD NO MENOR DEL 25% DEL PESO RELATIVO A LA CANTIDAD TOTAL DE LOS INGREDIENTES (1)~(5) , Y LA CAPA DE EMPLASTO EN UN TIPO W/O: 1 UN INGREDIENTE MEDICINAL. 2 UN POLIMERO HIDROFOBICO CON UNA TEMPERATURA DE TRANSICION DE CRISTAL (TG) DE 65 C A 35 C, 3 UN AGENTE DE FOMENTO DE ABSORCION PERCUTANEA, 4 AGUA, Y 5 UN POLIMERO HIDROFILICO SOLUBLE O CAPAZ DE CRECER EN AGUA; Y UN ADHESIVO MEDICO QUE CONTIENE UNA CAPA BASE POROSA EN LA CAPA DE EMPLASTO O EN CONTACTO CON LA CAPA DE EMPLASTO, QUE PERMITE LA LIBERACION ESTABLE DEL INGREDIENTE MEDICINAL, DE LOS AGENTES DE FOMENTO DE ABSORCION PERCUTANEA Y QUE MANTIENE LOS EFECTOS FARMACOLOGICOS DURANTE UN LARGO PERIODO.
ES91105933T 1990-04-18 1991-04-13 Dispositivo adhesivo para la administracion transdermica de un agente activo. Expired - Lifetime ES2075249T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2104294A JP2849937B2 (ja) 1990-04-18 1990-04-18 医療用貼付剤

Publications (1)

Publication Number Publication Date
ES2075249T3 true ES2075249T3 (es) 1995-10-01

Family

ID=14376914

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91105933T Expired - Lifetime ES2075249T3 (es) 1990-04-18 1991-04-13 Dispositivo adhesivo para la administracion transdermica de un agente activo.

Country Status (7)

Country Link
US (1) US5176916A (es)
EP (1) EP0452837B1 (es)
JP (1) JP2849937B2 (es)
AT (1) ATE126445T1 (es)
CA (1) CA2040698A1 (es)
DE (1) DE69112108T2 (es)
ES (1) ES2075249T3 (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69108512T2 (de) * 1990-05-17 1995-08-03 Hisamitsu Pharmaceutical Co Estradiol enthaltende transdermale zubereitung.
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
JP3523275B2 (ja) * 1992-03-26 2004-04-26 東光薬品工業株式会社 貼付剤
WO1993023019A1 (en) * 1992-05-11 1993-11-25 Sri International Transdermal drug delivery systems and related compositions and methods of use
US6162456A (en) * 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
JPH08512054A (ja) † 1993-06-25 1996-12-17 アルザ・コーポレーション 経皮系におけるポリ−ｎ−ビニルアミドの含有
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
JP2753800B2 (ja) * 1994-04-14 1998-05-20 日東電工株式会社 経皮吸収型製剤
US5552153A (en) * 1994-04-28 1996-09-03 Hoffman-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5580574A (en) * 1994-04-28 1996-12-03 Hoffmann-La Roche Inc. Pharmaceutical composition for transdermal delivery
US5795916A (en) * 1994-08-09 1998-08-18 Tsumura & Co. Composition of external preparation
JP4102901B2 (ja) * 1994-09-14 2008-06-18 スリーエム カンパニー 経皮薬剤導入用マトリックス
DE69535737T2 (de) * 1994-09-16 2009-04-09 Hisamitsu Pharmaceutical Co., Inc., Tosu-shi Pflaster zur externen anwendung
MX9702750A (es) 1994-10-28 1997-09-30 Kimberly Clark Wordlwide Inc Articulo absorbente autoadherente.
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5686083A (en) * 1994-12-08 1997-11-11 Schering-Plough Healthcare Products Inc. Compositions for treating corns and calluses
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
DE19512181C2 (de) 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermales System mit Ramipril und/oder Trandolapril als ACE-Hemmer
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
FR2739031B1 (fr) * 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
US5755758A (en) * 1995-11-07 1998-05-26 Medtronic, Inc. Intramuscular stimulation lead with enhanced infection resistance
TW411277B (en) * 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DK48997A (da) * 1997-04-30 1999-01-05 Coloplast As Klæbemiddel samt anvendelse af dette middel
US7150881B2 (en) * 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
JP4138910B2 (ja) * 1997-07-02 2008-08-27 帝國製薬株式会社 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
EP0891782B1 (en) * 1997-07-17 2005-05-25 Nitto Denko Corporation Medical adhesive sheet and production thereof
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
AU1728099A (en) 1997-12-22 1999-07-12 Alza Corporation Monoglyceride and ethyl palmitate permeation enhancer compositions
DE19800277B4 (de) * 1998-01-07 2004-09-02 Lts Lohmann Therapie-Systeme Ag Verfahren zur Rückgewinnung von Arzneistoffen aus Zubereitungen, deren Vorprodukten oder Abfällen
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
US6193996B1 (en) * 1998-04-02 2001-02-27 3M Innovative Properties Company Device for the transdermal delivery of diclofenac
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
DE19918105C1 (de) * 1999-04-22 2000-09-21 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem stark wirksamen Neuroleptikum
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
WO2000076485A1 (fr) * 1999-06-11 2000-12-21 Lintec Corporation Preparation sensible a l'humidite du type a absorption percutanee
DK1197209T3 (da) * 1999-07-15 2011-04-04 Hisamitsu Pharmaceutical Co Perkutant absorberbare præparater
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US6864274B2 (en) * 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6896897B2 (en) * 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020055531A1 (en) * 1999-07-23 2002-05-09 Elliott Farber Methods for treatment of inflammatory diseases
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
DE10033855A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
AU2001293559A1 (en) * 2000-09-19 2002-04-02 Dermal Therapy (Barbados) Inc. Topical analgesic compositions containing aliphatic polyamines and methods of using same
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
ATE464887T1 (de) * 2001-05-31 2010-05-15 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
WO2005021058A2 (en) 2003-09-02 2005-03-10 Coloplast A/S Adhesive composition comprising hydrophilic and hydrophobic silicone elastomers
JP4268527B2 (ja) * 2004-01-16 2009-05-27 積水化学工業株式会社 外用治療シート
WO2006082728A1 (ja) * 2005-02-04 2006-08-10 Hisamitsu Pharmaceutical Co., Inc. 経皮吸収貼付剤
DE102005058166A1 (de) 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
US20090017120A1 (en) * 2007-03-23 2009-01-15 Humco Holding Group, Inc. Phase stable lecithin organogel composition
US8182647B2 (en) * 2007-07-23 2012-05-22 Cohera Medical, Inc. Hydrophilic biodegradable adhesives
CN102781473B (zh) * 2009-11-12 2016-02-17 学校法人日本大学 外用药物组合物
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
JP5820469B2 (ja) 2010-04-30 2015-11-24 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダンの経皮組成物
CN103476404B (zh) 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
FR2975002B1 (fr) * 2011-05-12 2020-08-14 Jean-Noel Thorel Procede de traitement cosmetique de la peau en deux etapes successives
US9913812B2 (en) 2011-11-09 2018-03-13 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
CA2887705C (en) 2012-11-02 2018-07-24 Teikoku Pharma Usa, Inc. Propynylaminoindan transdermal compositions
EP3037088B1 (en) * 2013-08-23 2018-11-21 Hisamitsu Pharmaceutical Co., Inc. Cataplasm and method for producing same
JP6188933B2 (ja) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
CN106456561B (zh) 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
TW201609200A (zh) 2013-12-18 2016-03-16 丸石製藥股份有限公司 含水型貼劑
KR102094586B1 (ko) 2014-12-22 2020-03-27 히사미쓰 세이야꾸 가부시키가이샤 파프제
JP6632810B2 (ja) * 2015-03-31 2020-01-22 小林製薬株式会社 外用医薬組成物
CN110090206A (zh) * 2018-01-30 2019-08-06 日东电工株式会社 经皮吸收型制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2045618B (en) * 1979-04-03 1983-05-11 Hisamitsu Pharmaceutical Co Adhesive plaster
JPH0614957B2 (ja) * 1983-06-20 1994-03-02 帝国製薬株式会社 テ−プ状含水貼付剤及びその製造方法
JPS6124517A (ja) * 1984-07-11 1986-02-03 Nichiban Co Ltd 循環器疾患用貼布治療製剤
JPS61221121A (ja) * 1985-03-27 1986-10-01 Nitto Electric Ind Co Ltd テ−プ製剤
JPS61280426A (ja) * 1985-06-04 1986-12-11 Ikeda Mohandou:Kk 消炎鎮痛用貼付剤
US4732808A (en) * 1985-11-14 1988-03-22 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive sheet material
US4983396A (en) * 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
WO1988001170A1 (en) * 1986-08-20 1988-02-25 Teikoku Seiyaku Co., Ltd. Steroidal drug-containing preparation for external use
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
CH674618A5 (es) * 1987-04-02 1990-06-29 Ciba Geigy Ag
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
DE3823070A1 (de) * 1988-07-07 1990-02-22 Kettelhack Riker Pharma Gmbh Selbstklebendes heftpflaster
EP0359004A1 (en) * 1988-09-05 1990-03-21 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition for the treatment of hypertension

Also Published As

Publication number Publication date
CA2040698A1 (en) 1991-10-19
US5176916A (en) 1993-01-05
JP2849937B2 (ja) 1999-01-27
EP0452837A3 (en) 1992-03-04
DE69112108D1 (de) 1995-09-21
EP0452837B1 (en) 1995-08-16
ATE126445T1 (de) 1995-09-15
EP0452837A2 (en) 1991-10-23
JPH041127A (ja) 1992-01-06
DE69112108T2 (de) 1996-01-11

Similar Documents

Publication Publication Date Title
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
US5071644A (en) Topical drug delivery with thermo-irreversible gels
DK0550641T3 (da) Dispenseringsanordning indeholdende et hydrofobt medium
ES2075468T3 (es) Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
FI820467L (fi) Farmaceutiska kompositioner som frigoers kontinuerligt
ES2052016T3 (es) Composicion emulsionada.
IL115495A0 (en) Use and composition of an anti-sexually transmitted disease formulation
HU9802889D0 (en) Percutaneous absorption type preparation
IT1243745B (it) Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
EP0724885A4 (en) COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
PT90466A (pt) Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina
IE882898L (en) Solubility modulated drug delivery device
GR3025362T3 (en) Sol-controlled gelatine-based thermocolloidal matrix for peroral prolonged action administration forms.
SE8300577D0 (sv) Overdrag som tillforsekrar reglerad avgivning av akriva bestandsdelar fran biologiskt aktiva blandningar, i synnerhet farmaceutiska beredningar, jemte sett att framstella biologiskt aktiva blandningar med reglerad ....
ATE127683T1 (de) Stabile emulgierte tretinoin-cremeformulierungen.
MC2025A1 (fr) Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
ATE429217T1 (de) Nateglinid enthaltende hydrophile arzneimittelpräparate
DK78487D0 (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
DK0416722T3 (da) Farmaceutiske præparater med differentieret medikamentfrigivelseshastighed
CO4700301A1 (es) Dispositivo para suministro intravaginal de drogas para ad- ministracion de precursores de 17b-estradiol
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도
JPS643123A (en) Remedy for skin inflammation
JPS57185217A (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 452837

Country of ref document: ES